TGen's Drug Development Group to Use Mission3 Product-Lifecycle Software | GenomeWeb
NEW YORK (GenomeWeb News) - The Translational Genomics Research Institute’s TD2 drug-development arm has agreed to use product-lifecycle software from Mission3, the organizations said recently.
 
TD2 will use the company’s MissionFire and FastCrossing software to help manage its drug development process.
 
FastCrossing is a graphical, web-based tool used in application submissions, while MissionFire is used in document and project management.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.